Results 311 to 320 of about 626,622 (390)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. Weitz +19 more
semanticscholar +1 more source
Abstract Objectives Inflammatory bowel disease (IBD) is a chronic disorder linked to cardiovascular disease (CVD). However, the impact of histologic and clinical activity on this association remains unclear. Methods We conducted a nationwide cohort study in Sweden involving 59,168 IBD patients diagnosed in 1969–2017 with histologic evaluation and 91 ...
Jiangwei Sun +8 more
wiley +1 more source
ABSTRACT Introduction Although the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to
Sarah Berdot +17 more
wiley +1 more source
Associations of tumour somatic mutations with cancer-associated venous thromboembolism
Cornish N +6 more
europepmc +1 more source
Best evidence summary on anticoagulant management in patients with cancer-associated venous thromboembolism. [PDF]
Xiang X, Yu Y, Fang X, Zheng T, Qiao W.
europepmc +1 more source
The purpose of this study was to compare 30‐day complications between use of general and spinal anesthetic in patients with COPD and femoral neck fractures who underwent hip arthroplasty. Patients undergoing general anesthesia had a higher incidence of 30‐day mortality, hospital readmission, and surgical and medical complications.
David R. Christian +6 more
wiley +1 more source
Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin on Venous Thromboembolism in Cancer Patients. [PDF]
Jung HI, Geue C, Ciminata G, Lee EK.
europepmc +1 more source

